These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1615664)

  • 1. Ovarian cancer screening.
    Macri CI; DiSaia PJ
    West J Med; 1992 Jun; 156(6):652-3. PubMed ID: 1615664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and screening of ovarian cancer.
    Tortolero-Luna G; Mitchell MF; Rhodes-Morris HE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):1-23. PubMed ID: 8015758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making decisions about screening for ovarian cancer. Mass screening may not prove to be sound public health policy.
    Bell R
    BMJ; 2000 Apr; 320(7239):940; author reply 940-1. PubMed ID: 10787261
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial ovarian cancer screening.
    Stirling D; Porteous ME; Evans DG; Pichert G; Steel M
    J Clin Oncol; 2006 Feb; 24(6):e11. PubMed ID: 16484689
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for ovarian cancer: recommendations and rationale. American College of Physicians.
    Ann Intern Med; 1994 Jul; 121(2):141-2. PubMed ID: 8017728
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for ovarian cancer.
    Jacobs I; Oram D
    Biomed Pharmacother; 1988; 42(9):589-96. PubMed ID: 3071382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening and psychosocial issues: relevance to clinical practice.
    Basen-Engquist K
    Gynecol Oncol; 1997 May; 65(2):195-6. PubMed ID: 9159324
    [No Abstract]   [Full Text] [Related]  

  • 9. The NIH Consensus Conference on Ovarian Cancer: screening, treatment, and follow-up.
    Trimble EL
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S1-3. PubMed ID: 7835792
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian cancer screening: still waiting for the right answer.
    Ellwood D
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):447. PubMed ID: 19780722
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic, biochemical, and multimodal approaches to screening for ovarian cancer.
    Jacobs I
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S22-7. PubMed ID: 7835805
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for ovarian cancer: not worthwhile for most patients.
    Wong JG; Feussner JR
    N C Med J; 1993 Sep; 54(9):438-40. PubMed ID: 8232615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of carcinoembryonic antigen in puncture fluid of cystic ovarian tumors and ovarian cysts].
    Büttner HH; Kunze M; Voss P
    Gynakol Rundsch; 1988; 28 Suppl 2():179-80. PubMed ID: 3234915
    [No Abstract]   [Full Text] [Related]  

  • 14. [Screening for ovarian cancers: critical analysis].
    Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
    Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer screening: a primary care guide.
    Thompson SD
    Lippincotts Prim Care Pract; 1998; 2(3):244-50. PubMed ID: 9644439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer screening for women older than 40 years of age.
    Runowicz CD; Goldberg GL; Smith HO
    Obstet Gynecol Clin North Am; 1993 Jun; 20(2):391-408. PubMed ID: 8367140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood test for ovarian cancer may be 99% accurate.
    McBride D
    ONS Connect; 2008 Jun; 23(6):25. PubMed ID: 18572874
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CEA--a parameter in the course of chemotherapy of ovarian cancer].
    Urdl W; Pickel H; Pürstner P; Schrödl P
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():90-7. PubMed ID: 7194302
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma carcinoembryonic antigen levels in ovarian cancer patients: a chart review and survey of published data.
    Stall KE; Martin EW
    J Reprod Med; 1981 Feb; 26(2):73-9. PubMed ID: 7012337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.